T2 Biosystems, Inc. (TTOO) Financials
TTOO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 43.3 million | 62.5 million |
2023-06-30 | 37.1 million | 73.6 million |
2023-03-31 | 32.7 million | 82.6 million |
2022-12-31 | 34.4 million | 74.4 million |
TTOO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -13.4 million | 877000 |
2023-06-30 | -12.4 million | 913000 |
2023-03-31 | -13.1 million | 1.8 million |
2022-12-31 | -10.4 million | 1.0 million |
TTOO Net Income
No data available :(
TTOO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 24.3 million | - | 8.6 million |
2023-06-30 | 16.1 million | - | 8.9 million |
2023-03-31 | 10.1 million | - | 9.2 million |
2022-12-31 | 10.3 million | - | 9.6 million |
TTOO Shares Outstanding
TTOO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 13000 | 2.7 million | 6.0 million | - |
2023-06-30 | 33000 | 3.9 million | 6.3 million | - |
2023-03-31 | 120000 | 4.5 million | 7.3 million | - |
2022-12-31 | 36000 | 4.9 million | 6.6 million | - |
TTOO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 1.5 million | 3.9 million |
2023-06-30 | 2.0 million | 4.9 million |
2023-03-31 | 2.1 million | 4.0 million |
2022-12-31 | 5.5 million | 3.8 million |
TTOO
Price: $3
52 week price:
Payout Ratio Range:
Earnings Per Share: -35.62 USD
P/E Ratio: -0.14
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 168600
Ebitda: -11.7 millionMarket Capitalization: 14.0 million